Global COVID-19 IgM IgG Rapid Test Kits Market Overview And Scope:
Global COVID-19 IgM IgG Rapid Test Kits Market Size was estimated at USD 6560 million in 2022 and is projected to reach USD 11720 million by 2028, exhibiting a CAGR of 10.15% during the forecast period.
The Global COVID-19 IgM IgG Rapid Test Kits Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of COVID-19 IgM IgG Rapid Test Kits utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Beijing Wantai, Livzon Diagnostics, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech
Global COVID-19 IgM IgG Rapid Test Kits Market Segmentation
By Type, COVID-19 IgM IgG Rapid Test Kits market has been segmented into:
RDT(Rapid Diagnostic Test)
ELISA(Enzyme-linked Immunosorbent Aassay)
Neutralization Assay
By Application, COVID-19 IgM IgG Rapid Test Kits market has been segmented into:
Hospital
Special Clinic
Research Institutions
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The COVID-19 IgM IgG Rapid Test Kits market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the COVID-19 IgM IgG Rapid Test Kits market.
Top Key Players Covered in COVID-19 IgM IgG Rapid Test Kits market are:
Cellex
RayBiotech
Biopanda
BioMedomics
GenBody
SD Biosensor
Advaite
Premier Biotech
Epitope Diagnostics
CTK Biotech
Creative Diagnostics
Eagle Biosciences
Sure Biotech
Sugentech
Sensing self
Euroimmun AG
PharmACT
Liming Bio
Beijing Wantai
Livzon Diagnostics
Shenzhen BioEasy Biotechnology
Orient Gene Biotech
INNOVITA
Dynamiker
Guangzhou Wonfo Bio-Tech
Objective to buy this Report:
1. COVID-19 IgM IgG Rapid Test Kits analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with COVID-19 IgM IgG Rapid Test Kits market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: COVID-19 IgM IgG Rapid Test Kits Market by Type
5.1 COVID-19 IgM IgG Rapid Test Kits Market Overview Snapshot and Growth Engine
5.2 COVID-19 IgM IgG Rapid Test Kits Market Overview
5.3 RDT(Rapid Diagnostic Test)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 RDT(Rapid Diagnostic Test): Geographic Segmentation
5.4 ELISA(Enzyme-linked Immunosorbent Aassay)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 ELISA(Enzyme-linked Immunosorbent Aassay): Geographic Segmentation
5.5 Neutralization Assay
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Neutralization Assay: Geographic Segmentation
Chapter 6: COVID-19 IgM IgG Rapid Test Kits Market by Application
6.1 COVID-19 IgM IgG Rapid Test Kits Market Overview Snapshot and Growth Engine
6.2 COVID-19 IgM IgG Rapid Test Kits Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Special Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Special Clinic: Geographic Segmentation
6.5 Research Institutions
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Research Institutions: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 COVID-19 IgM IgG Rapid Test Kits Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 COVID-19 IgM IgG Rapid Test Kits Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 COVID-19 IgM IgG Rapid Test Kits Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CELLEX
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 RAYBIOTECH
7.4 BIOPANDA
7.5 BIOMEDOMICS
7.6 GENBODY
7.7 SD BIOSENSOR
7.8 ADVAITE
7.9 PREMIER BIOTECH
7.10 EPITOPE DIAGNOSTICS
7.11 CTK BIOTECH
7.12 CREATIVE DIAGNOSTICS
7.13 EAGLE BIOSCIENCES
7.14 SURE BIOTECH
7.15 SUGENTECH
7.16 SENSING SELF
7.17 EUROIMMUN AG
7.18 PHARMACT
7.19 LIMING BIO
7.20 BEIJING WANTAI
7.21 LIVZON DIAGNOSTICS
7.22 SHENZHEN BIOEASY BIOTECHNOLOGY
7.23 ORIENT GENE BIOTECH
7.24 INNOVITA
7.25 DYNAMIKER
7.26 GUANGZHOU WONFO BIO-TECH
Chapter 8: Global COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 RDT(Rapid Diagnostic Test)
8.2.2 ELISA(Enzyme-linked Immunosorbent Aassay)
8.2.3 Neutralization Assay
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Special Clinic
8.3.3 Research Institutions
Chapter 9: North America COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 RDT(Rapid Diagnostic Test)
9.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
9.4.3 Neutralization Assay
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Special Clinic
9.5.3 Research Institutions
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 RDT(Rapid Diagnostic Test)
10.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
10.4.3 Neutralization Assay
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Special Clinic
10.5.3 Research Institutions
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 RDT(Rapid Diagnostic Test)
11.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
11.4.3 Neutralization Assay
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Special Clinic
11.5.3 Research Institutions
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 RDT(Rapid Diagnostic Test)
12.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
12.4.3 Neutralization Assay
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Special Clinic
12.5.3 Research Institutions
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 RDT(Rapid Diagnostic Test)
13.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
13.4.3 Neutralization Assay
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Special Clinic
13.5.3 Research Institutions
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America COVID-19 IgM IgG Rapid Test Kits Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 RDT(Rapid Diagnostic Test)
14.4.2 ELISA(Enzyme-linked Immunosorbent Aassay)
14.4.3 Neutralization Assay
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Special Clinic
14.5.3 Research Institutions
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
COVID-19 IgM IgG Rapid Test Kits Scope:
|
Report Data
|
COVID-19 IgM IgG Rapid Test Kits Market
|
|
COVID-19 IgM IgG Rapid Test Kits Market Size in 2022
|
USD 6560.00 million
|
|
COVID-19 IgM IgG Rapid Test Kits CAGR 2023 - 2030
|
10.15%
|
|
COVID-19 IgM IgG Rapid Test Kits Base Year
|
2022
|
|
COVID-19 IgM IgG Rapid Test Kits Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Beijing Wantai, Livzon Diagnostics, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech.
|
|
Key Segments
|
By Type
RDT(Rapid Diagnostic Test)
ELISA(Enzyme-linked Immunosorbent Aassay)
Neutralization Assay
By Applications
Hospital
Special Clinic
Research Institutions
|
